- Cancer Genetics (CGIX): Q3 GAAP EPS of -$0.31 misses by $0.13.
- Revenue of $5.94M (-26.0% Y/Y) misses by $1.63M.
- Press Release
Cancer Genetics misses by $0.13, misses on revenue
Recommended For You
About VYNT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| VYNT | - | - |
| Vyant Bio, Inc. | ||